OverviewChartNewsTraderScreen

Citi Discount Zert TEVA 26.06.202.../  DE000KJ4XJN4  /

Frankfurt Zert./CITI
2024-04-09  9:34:17 AM Chg.-0.020 Bid2:22:58 PM Ask- Underlying Strike price Expiration date Option type
12.140EUR -0.16% -
Bid Size: -		 -
Ask Size: -		 Teva Pharmaceutical ... - - 2024-06-26 Call
GlobeNewswire 05-02 Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
GlobeNewswire 04-30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire 04-24 Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire 04-19 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire 04-16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire 04-03 Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
GlobeNewswire 03-22 Alvotech Announces Increase in Number of Own Shares
GlobeNewswire 03-20 Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
GlobeNewswire 03-06 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
GlobeNewswire 03-05 Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
GlobeNewswire 02-29 Alvotech Appoints Interim Chief Quality Officer
GlobeNewswire 02-26 Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...
GlobeNewswire 02-24 Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interc...
GlobeNewswire 02-21 AdhereTech Announces Appointment of Paul Sekhri to Board of Directors
GlobeNewswire 02-15 Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
GlobeNewswire 02-08 Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to...
GlobeNewswire 01-31 Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic ...
GlobeNewswire 01-29 Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Bios...
GlobeNewswire 01-19 Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
GlobeNewswire 01-10 STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
GlobeNewswire 01-03 Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT...
GlobeNewswire 2023-11-29 Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Bios...
GlobeNewswire 2023-11-28 Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
GlobeNewswire 2023-11-21 Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Hos...
GlobeNewswire 2023-11-14 Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki™ (AVT04), the First...